One Day, Three IRD Gene Therapy Triumphs
January 8, 2025, was no ordinary day in the world of gene therapy for inherited retinal diseases (IRDs)—it was a…
Exegenesis Bio Provides Updates on nAMD Gene Therapies
The race for an effective alternative to anti-VEGF therapies in nAMD heats up. Exegenesis Bio (Philadelphia, USA), a clinical-stage global…
latest posts
